Sign in

NCT07044843Completed

Oxygen Therapy During Exercise Training in Inpatient Rehabilitation in Chronic Lung Disease- Does it Matter?

Source: ClinicalTrials.gov · Last updated 10 Sept 2026

Brief summary (registry, in English)

The aim of the current study is the effect of SSOT during a 3-weeks inpatient pulmonary rehabilitation program. Further aim is to analyze exercise endurance, distinguishing between those exercising whilst breathing air at 760m "normoxia", breathing air at approx. 1600m "hypoxia", or breathing SSOT at 760m "hyperoxia" conditions during inpatient pulmonary rehabilitation. The objective of the study is to provide long-awaited data concerning the use of SSOT during training. To date, it is not clear whether patients with chronic lung diseases who reveal a SpO2 \> 88% at rest but desaturate during exercise and thus may not qualify for long-term oxygen therapy undergoing PR benefit from supplemental oxygen.

Status (registry)
Completed
Study type
Interventional
Enrollment
54 (actual)
First submitted
20 Jun 2025
Start date
23 Jul 2025
Primary completion date
23 Dec 2025
Lead sponsor
Eastern Switzerland University of Applied Sciences
Diseases
COPD
NCT number
NCT07044843

What you commit to

  • Study type: Interventional
  • Participants enrolled: 54
  • From 23 Jul 2025 to the primary completion date, 23 Dec 2025
  • 2 sites in 2 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • long-term oxygen therapy
  • unstable condition requiring adaptation of pharmacologic and other treatment modalities or requirement of intensive care or relevant severe concomitant disease

Other illness

  • inability to follow the procedures of the study, e.g. due to language problems psychological disorders, neurological or orthopedic problems with walking disability or inability to ride a bicycle

Other

  • Severe daytime resting hypoxemia (SpO2 \< 88%)
  • women who are pregnant or breast feeding
  • enrolment in another clinical trial with active treatment.

Who the study is looking for

  • aged ≥ 18 years
  • stable condition \> 3 weeks (e.g. no exacerbations)
  • resting SpO2 ≥ 88% and exercise induced hypoxemia defined by a fall in SpO2 by ≥ 4% and/or below 90% during a 6-minute walk test (6MWT)
  • informed consent as documented by signature.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Eastern Switzerland University of Applied Sciences
Coordinator of this site? Confirm its status
Sankt GallenSwitzerlandUnknown status
National center for cardiology and internal medicine
Coordinator of this site? Confirm its status
BishkekKyrgyzstanUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.